BEACON Pharmaceutical Limited
Beacon Pharmaceutical, the first and the only high-tech lyophilized anticancer drugs manufacturing facility of Bangladesh has taken initiative to export its world class products. Director Marketing of Beacon Pharmaceutical Mohammad Akhter Hussain recently visited six North African nations as a delegate of Bangladesh Pharmaceutical Marketing Mission. Bangladesh Association of Pharmaceutical Industries and Export Promotion Bureau jointly organized the mission to explore export market opportunities in Egypt, Libya, Tunisia, Algeria, Morocco and Sudan during September 05 to 20, 2005.As a member of the Marketing Mission Mr. Akhter had fruitful meetings with the Health Ministry, Drugs Administration and Pharmaceuticals Importers of those six countries. He explained important technical aspects of Beacon Pharmaceutical through a computer aided power point presentation. Mr. Akhter mentioned that Beacon Pharmaceutical has been designed by European consultants in order to be one of the finest facilities in the world. Spread over a magnificent landscape of 45 bighas of land the Tk. 200 crore projects have been established to conform FDA-USA, MHRA-UK, TGA-Australia and CGMP-WHO standards. Equipped with the most automated machineries Beacon Pharmaceutical will manufacture specialized drugs from anti-cancer, hormone and cardiovascular therapeutic classes. Mr. Akhter distributed product list and other promotional materials of Beacon pharmaceutical to regulatory authorities and other prospective buyers. Most of them had shown their keen interest to import anticancer and other drugs of Beacon Pharmaceutical. Some of the importers had expressed their willingness to be the sole distributor of Beacon Pharmaceutical in their respective countries. Beacon Pharmaceutical is hopeful to export anticancer and other drugs after .We are committed to the highest ethical standards and our products and processes are of the highest quality. Our business practices and processes are designed to achieve quality results that exceed the expectations of patients, physicians, customers, business partners and regulators. At Beacon, Quality is ingrained in the work of our colleagues and all our values. We have a relentless passion for quality in everything we do. Product quality is considered to be a prime determinant for successful marketing of the pharmaceutical products. To achieve this objective the project has been equipped with modern machinery; qualified, skilled and experienced manpower. Furthermore, finest quality raw materials are being used. The factory is built in full compliance with MCA regulatory norms and will also comply ISO 14000 for environment. Besides, the Managing Director is intensively associated with the pharmaceutical industry for the last 10 years and has the marketing skills and administrative acumen to successfully run a pharmaceutical company of this magnitude and standard.
Thursday, April 29, 2010
Pharmaceutical-Razu
BEACON Pharmaceutical Limited
Beacon Pharmaceutical, the first and the only high-tech lyophilized anticancer drugs manufacturing facility of Bangladesh has taken initiative to export its world class products. Director Marketing of Beacon Pharmaceutical Mohammad Akhter Hussain recently visited six North African nations as a delegate of Bangladesh Pharmaceutical Marketing Mission. Bangladesh Association of Pharmaceutical Industries and Export Promotion Bureau jointly organized the mission to explore export market opportunities in Egypt, Libya, Tunisia, Algeria, Morocco and Sudan during September As a member of the Marketing Mission Mr. Akhter had fruitful meetings with the Health Ministry, Drugs Administration and Pharmaceuticals Importers of those six countries. He explained important technical aspects of Beacon Pharmaceutical through a computer aided power point presentation. Mr. Akhter mentioned that Beacon Pharmaceutical has been designed by European consultants in order to be one of the finest facilities in the world. Spread over a magnificent landscape of 45 bighas of land the Tk. 200 coror. Project has been established to conform FDA-USA, MHRA-UK, TGA-Australia and CGMP-WHO standards. Equipped with the most automated machineries Beacon Pharmaceutical will manufacture specialized drugs from anti-cancer, hormone and cardiovascular therapeutic classes. Mr. Akhter distributed product list and other promotional materials of Beacon pharmaceutical to regulatory authorities and other prospective buyers. Most of them had shown their keen interest to import anticancer and other drugs of Beacon Pharmaceutical Some of the importers had expressed their willingness to be the sole distributor of Beacon Pharmaceutical in their respective countries. Beacon Pharmaceutical is hopeful to export anticancer and other drugs after meeting countries demand. We are committed to the highest ethical standards and our products and processes are of the highest quality. Our business practices and processes are designed to achieve quality results that exceed the expectations of patients, physicians, customers, business partners and regulators. At Beacon, Quality is ingrained in the work of our colleagues and all our values. We have a relentless passion for quality in everything we do.
Beacon Pharmaceutical, the first and the only high-tech lyophilized anticancer drugs manufacturing facility of Bangladesh has taken initiative to export its world class products. Director Marketing of Beacon Pharmaceutical Mohammad Akhter Hussain recently visited six North African nations as a delegate of Bangladesh Pharmaceutical Marketing Mission. Bangladesh Association of Pharmaceutical Industries and Export Promotion Bureau jointly organized the mission to explore export market opportunities in Egypt, Libya, Tunisia, Algeria, Morocco and Sudan during September As a member of the Marketing Mission Mr. Akhter had fruitful meetings with the Health Ministry, Drugs Administration and Pharmaceuticals Importers of those six countries. He explained important technical aspects of Beacon Pharmaceutical through a computer aided power point presentation. Mr. Akhter mentioned that Beacon Pharmaceutical has been designed by European consultants in order to be one of the finest facilities in the world. Spread over a magnificent landscape of 45 bighas of land the Tk. 200 coror. Project has been established to conform FDA-USA, MHRA-UK, TGA-Australia and CGMP-WHO standards. Equipped with the most automated machineries Beacon Pharmaceutical will manufacture specialized drugs from anti-cancer, hormone and cardiovascular therapeutic classes. Mr. Akhter distributed product list and other promotional materials of Beacon pharmaceutical to regulatory authorities and other prospective buyers. Most of them had shown their keen interest to import anticancer and other drugs of Beacon Pharmaceutical Some of the importers had expressed their willingness to be the sole distributor of Beacon Pharmaceutical in their respective countries. Beacon Pharmaceutical is hopeful to export anticancer and other drugs after meeting countries demand. We are committed to the highest ethical standards and our products and processes are of the highest quality. Our business practices and processes are designed to achieve quality results that exceed the expectations of patients, physicians, customers, business partners and regulators. At Beacon, Quality is ingrained in the work of our colleagues and all our values. We have a relentless passion for quality in everything we do.
Pharmaceutical-Razu
BEACON Pharmaceutical Limited
Beacon Pharmaceutical, the first and the only high-tech lyophilized anticancer drugs manufacturing facility of Bangladesh has taken initiative to export its world class products. Director Marketing of Beacon Pharmaceutical Mohammad Akhter Hussain recently visited six North African nations as a delegate of Bangladesh Pharmaceutical Marketing Mission. Bangladesh Association of Pharmaceutical Industries and Export Promotion Bureau jointly organized the mission to explore export market opportunities in Egypt, Libya, Tunisia, Algeria, Morocco and Sudan during September As a member of the Marketing Mission Mr. Akhter had fruitful meetings with the Health Ministry, Drugs Administration and Pharmaceuticals Importers of those six countries. He explained important technical aspects of Beacon Pharmaceutical through a computer aided power point presentation. Mr. Akhter mentioned that Beacon Pharmaceutical has been designed by European consultants in order to be one of the finest facilities in the world. Spread over a magnificent landscape of 45 bighas of land the Tk. 200 coror. Project has been established to conform FDA-USA, MHRA-UK, TGA-Australia and CGMP-WHO standards. Equipped with the most automated machineries Beacon Pharmaceutical will manufacture specialized drugs from anti-cancer, hormone and cardiovascular therapeutic classes. Mr. Akhter distributed product list and other promotional materials of Beacon pharmaceutical to regulatory authorities and other prospective buyers. Most of them had shown their keen interest to import anticancer and other drugs of Beacon Pharmaceutical Some of the importers had expressed their willingness to be the sole distributor of Beacon Pharmaceutical in their respective countries. Beacon Pharmaceutical is hopeful to export anticancer and other drugs after meeting countries demand. We are committed to the highest ethical standards and our products and processes are of the highest quality. Our business practices and processes are designed to achieve quality results that exceed the expectations of patients, physicians, customers, business partners and regulators. At Beacon, Quality is ingrained in the work of our colleagues and all our values. We have a relentless passion for quality in everything we do.
Beacon Pharmaceutical, the first and the only high-tech lyophilized anticancer drugs manufacturing facility of Bangladesh has taken initiative to export its world class products. Director Marketing of Beacon Pharmaceutical Mohammad Akhter Hussain recently visited six North African nations as a delegate of Bangladesh Pharmaceutical Marketing Mission. Bangladesh Association of Pharmaceutical Industries and Export Promotion Bureau jointly organized the mission to explore export market opportunities in Egypt, Libya, Tunisia, Algeria, Morocco and Sudan during September As a member of the Marketing Mission Mr. Akhter had fruitful meetings with the Health Ministry, Drugs Administration and Pharmaceuticals Importers of those six countries. He explained important technical aspects of Beacon Pharmaceutical through a computer aided power point presentation. Mr. Akhter mentioned that Beacon Pharmaceutical has been designed by European consultants in order to be one of the finest facilities in the world. Spread over a magnificent landscape of 45 bighas of land the Tk. 200 coror. Project has been established to conform FDA-USA, MHRA-UK, TGA-Australia and CGMP-WHO standards. Equipped with the most automated machineries Beacon Pharmaceutical will manufacture specialized drugs from anti-cancer, hormone and cardiovascular therapeutic classes. Mr. Akhter distributed product list and other promotional materials of Beacon pharmaceutical to regulatory authorities and other prospective buyers. Most of them had shown their keen interest to import anticancer and other drugs of Beacon Pharmaceutical Some of the importers had expressed their willingness to be the sole distributor of Beacon Pharmaceutical in their respective countries. Beacon Pharmaceutical is hopeful to export anticancer and other drugs after meeting countries demand. We are committed to the highest ethical standards and our products and processes are of the highest quality. Our business practices and processes are designed to achieve quality results that exceed the expectations of patients, physicians, customers, business partners and regulators. At Beacon, Quality is ingrained in the work of our colleagues and all our values. We have a relentless passion for quality in everything we do.
Wednesday, April 28, 2010
Pharmaceutical- Razu
OPSONIN Pharmaceutical Limited
Opsonin Pharmaceutical Limited is one of the leading manufacturers of various medicines and health care products in Bangladesh. Opsonin is in pharmaceutical business since 1956 as a manufacturer with the ultimate goal of serving the mankind and the man behind the mankind. Opsonin Pharmaceutical Limited has more than 2, 100 employees which includes diversified professional team like pharmacist, chemist, biochemist, microbiologist, engineer, medical professional, IT professional, chartered accountant, cost and management accountant business graduates etc. Our manufacturing facilities in Barisal, a southern district of Bangladesh carries out the manufacturing and packaging of all the products sold by the company. The production units are equipped with sophisticated machines made by world-renowned manufacturers. To name a few are Tablet Compression Machine from Manesty of the U. K.; Tablet Coating Machine from GS Coater of Italy; Advanced formatting Technology Blisterpack Machine from Horn Noach of Germany; Auto Cartoning Machine from Promatic of Italy and many more. Experienced validation engineers qualifies these highly sophisticated machines and these are being operated by highly skilled production and engineering personnel. The process through which the products are made in these machines are also validated, which guarantees that Current Good Manufacturing Practices (cGMP) prevail while goods are being produced. Opsonin Pharmaceutical Limited has adopted the world Health Organization's (WHO) Guidelines on GMP in the Quality Management System. Quality Assurance procedures ensure that the quality of the products is maintained by strict compliance with international pharmacopoeias specifications on raw materials, packaging materials and finished products.
Opsonin Pharmaceutical Limited is one of the leading manufacturers of various medicines and health care products in Bangladesh. Opsonin is in pharmaceutical business since 1956 as a manufacturer with the ultimate goal of serving the mankind and the man behind the mankind. Opsonin Pharmaceutical Limited has more than 2, 100 employees which includes diversified professional team like pharmacist, chemist, biochemist, microbiologist, engineer, medical professional, IT professional, chartered accountant, cost and management accountant business graduates etc. Our manufacturing facilities in Barisal, a southern district of Bangladesh carries out the manufacturing and packaging of all the products sold by the company. The production units are equipped with sophisticated machines made by world-renowned manufacturers. To name a few are Tablet Compression Machine from Manesty of the U. K.; Tablet Coating Machine from GS Coater of Italy; Advanced formatting Technology Blisterpack Machine from Horn Noach of Germany; Auto Cartoning Machine from Promatic of Italy and many more. Experienced validation engineers qualifies these highly sophisticated machines and these are being operated by highly skilled production and engineering personnel. The process through which the products are made in these machines are also validated, which guarantees that Current Good Manufacturing Practices (cGMP) prevail while goods are being produced. Opsonin Pharmaceutical Limited has adopted the world Health Organization's (WHO) Guidelines on GMP in the Quality Management System. Quality Assurance procedures ensure that the quality of the products is maintained by strict compliance with international pharmacopoeias specifications on raw materials, packaging materials and finished products.
Pharmaceutical-Razu
GENERAL Pharmaceutical Limited
General Pharmaceuticals Ltd. (GPL) is one of the fastest growing pharmaceutical finished formulation manufacturing companies in Bangladesh with a mission to provide innovative high quality range of healthcare products. GPL has been striving for more than 18 years and has devoted entirely to the development of excellent pharmaceutical finished products. Relentlessly pursuing scientific knowledge, building the strength and developing the vision required to compete with the best in the future GPL has grown into a company that boosts of world class products, excellent production facilities and quality professionals. GPL has crossed numerous milestones in its journey. Turnover has grown multifold;
Introduced several new life saving molecules for the first time in Bangladesh;
Possesses an excellent production infrastructure; and It has created effective systems and built committed teams of professionals, which ensure that General Pharmaceutical is fully prepared and ready to successfully take on the challenges of the future. General Pharmaceuticals has about 212 dosage forms for marketing within Bangladesh There are 2000 skilled professional are working in GPL inclusive of 900 Sales & Marketing Force. The distribution network is spread all over Bangladesh with a professional team of 500 distributions personnel. Launching new products in every month, maintaining the strong position in the market since their inception in 1987.In recent years GPL has entered into export fields by registering its products in Viet Nam, Kenya, Hong Kong, Macau, Mauritius, Myanmar, Sri Lanka & Maldives. In this connection GPL is also aiming to export their pharmaceutical finished products to other countries of South East Asia, Middle East and Africa and Latin America (for brief information please clicks International Marketing).
General Pharmaceuticals Ltd. (GPL) is one of the fastest growing pharmaceutical finished formulation manufacturing companies in Bangladesh with a mission to provide innovative high quality range of healthcare products. GPL has been striving for more than 18 years and has devoted entirely to the development of excellent pharmaceutical finished products. Relentlessly pursuing scientific knowledge, building the strength and developing the vision required to compete with the best in the future GPL has grown into a company that boosts of world class products, excellent production facilities and quality professionals. GPL has crossed numerous milestones in its journey. Turnover has grown multifold;
Introduced several new life saving molecules for the first time in Bangladesh;
Possesses an excellent production infrastructure; and It has created effective systems and built committed teams of professionals, which ensure that General Pharmaceutical is fully prepared and ready to successfully take on the challenges of the future. General Pharmaceuticals has about 212 dosage forms for marketing within Bangladesh There are 2000 skilled professional are working in GPL inclusive of 900 Sales & Marketing Force. The distribution network is spread all over Bangladesh with a professional team of 500 distributions personnel. Launching new products in every month, maintaining the strong position in the market since their inception in 1987.In recent years GPL has entered into export fields by registering its products in Viet Nam, Kenya, Hong Kong, Macau, Mauritius, Myanmar, Sri Lanka & Maldives. In this connection GPL is also aiming to export their pharmaceutical finished products to other countries of South East Asia, Middle East and Africa and Latin America (for brief information please clicks International Marketing).
Tuesday, April 27, 2010
Pharmaceutical-Razu
POPULAR Pharmaceutical limited
Popular Pharmaceuticals Ltd. (PPL), the pioneer manufacturer of Human Insulin in Bangladesh, is a company of Popular Group, the leading corporate house in the private sector Health Care Management of the country. PPL is manufacturing and marketing its high quality and wide variety of product range both in home and abroad.PPL has an aim to lead the market of Branded Generics in Bangladesh with a portfolio of vital molecules while at the same time, progressing for the next wave of novel products
The State of the Art manufacturing facilities of Popular Pharmaceuticals Ltd. (PPL), is located in an industrial area close to the International Airport of the capital city, Dhaka. The total land area of this site is 22,952 m2 with a covered area of 13,509 m2.The manufacturing site is built with strict compliance to WHO cGMP standards and also to meet US FDA and UK MHRA requirements.The project involved an investment of BDT 2,000 M (US$ 30 M approx.); the ever highest initial investment for a pharmaceutical plant in Bangladesh and financed by six leading Financial Institutions and Banks. Through captivating marketing strategies coupled with optimum productivity across all its activities with quality People, Plant and Product, PPL is committed to deliver top tier performance round the year. PPL is continuously investing in diversifying the ranges of products and services to complement the aura with all the major therapeutic areas.Delivering PPL’s core values through a responsible approach to business by introducing differentiated medicines that make a real contribution to the health sector of Bangladesh, PPL also aims to create enduring value for the society, and deliver a sustained financial performance that will match the best in the industry.The growing demand for new medicines is driven by increasing population and improved life expectancy as modern medicine supports an ageing population. Popular Pharmaceuticals Ltd. intends to focus its skills and resources on all major therapeutic areas that represent majority of the burden of disease profiles of Bangladesh.Popular Pharmaceuticals Ltd. is also committed to delivering new, medically important and commercially successful products to the market every year. Along with its commitment to competitiveness and high performance, PPL will continue to be led by its core values to achieve sustainable success.Efficient pharmaceutical business requires transparent, quality assured processes which are acceptable to regulatory authorities worldwide in addition to the use of complementary new technologies. PPL is committed to the best use of available technology and expertise of the time and thereby ensuring continuous improvements with regards to effectiveness and efficiency.
Popular Pharmaceuticals Ltd. (PPL), the pioneer manufacturer of Human Insulin in Bangladesh, is a company of Popular Group, the leading corporate house in the private sector Health Care Management of the country. PPL is manufacturing and marketing its high quality and wide variety of product range both in home and abroad.PPL has an aim to lead the market of Branded Generics in Bangladesh with a portfolio of vital molecules while at the same time, progressing for the next wave of novel products
The State of the Art manufacturing facilities of Popular Pharmaceuticals Ltd. (PPL), is located in an industrial area close to the International Airport of the capital city, Dhaka. The total land area of this site is 22,952 m2 with a covered area of 13,509 m2.The manufacturing site is built with strict compliance to WHO cGMP standards and also to meet US FDA and UK MHRA requirements.The project involved an investment of BDT 2,000 M (US$ 30 M approx.); the ever highest initial investment for a pharmaceutical plant in Bangladesh and financed by six leading Financial Institutions and Banks. Through captivating marketing strategies coupled with optimum productivity across all its activities with quality People, Plant and Product, PPL is committed to deliver top tier performance round the year. PPL is continuously investing in diversifying the ranges of products and services to complement the aura with all the major therapeutic areas.Delivering PPL’s core values through a responsible approach to business by introducing differentiated medicines that make a real contribution to the health sector of Bangladesh, PPL also aims to create enduring value for the society, and deliver a sustained financial performance that will match the best in the industry.The growing demand for new medicines is driven by increasing population and improved life expectancy as modern medicine supports an ageing population. Popular Pharmaceuticals Ltd. intends to focus its skills and resources on all major therapeutic areas that represent majority of the burden of disease profiles of Bangladesh.Popular Pharmaceuticals Ltd. is also committed to delivering new, medically important and commercially successful products to the market every year. Along with its commitment to competitiveness and high performance, PPL will continue to be led by its core values to achieve sustainable success.Efficient pharmaceutical business requires transparent, quality assured processes which are acceptable to regulatory authorities worldwide in addition to the use of complementary new technologies. PPL is committed to the best use of available technology and expertise of the time and thereby ensuring continuous improvements with regards to effectiveness and efficiency.
Pharmaceuticals-Razu
NAVANA Pharmaceuticals Limited
N A V A N A Pharmaceuticals Ltd. is a Business Unit of Islam Group, which is one of the largest groups of Industries in Bangladesh having diversifying activities like Real estate, Construction, Information Technology, Banking, Fertilizer, Medical College& Hospital, Pharmaceuticals, Nursing Institutes, Agro & Poultry products and some other Business lines.
Navana’s mission is to build strengths carefully in important areas that offer the resources for tomorrow’s business opportunities.
to build customer’s trust as “Quality Company” both in products and services
to ensure health and sustainable growth of the company
to maintain the quality in all areas of operations by continuous development of Human Resource
Navana’s vision is to play the leading role in the country’s health sector by providing safe and effective medicine of high quality which will bring benefit to patients through improved longevity and quality of life. The pharmaceutical business is a composite of a variety professional background, including Pharmacist, Chemist, Biochemist, Engineer, Marketing Professional, Accountant & others. The founder chairman made certain commitments of principle at the onset to guide the company as it pursued is goals.
Act always with honesty, ethical and moral standards.
Adhere to standards of integrity in business and in products that benefit patients and inspire trust in Navana’s good name.
Embrace hands-on work ethic and a commitment to Navana’s success.
Exercise community stewardship by pursuing growth to provide more jobs for more families.
Share the blessings of success by giving first to the community and then to the world Leading Edge
Navana has gained a leading edge in many important therapeutic groups including Antibiotics, Antiulcer ants, Anitimigraines, Antivertigoes, Vitamins / Minerals, Opioid antagonist / Drug addiction treatment drugs. Navana Pharmaceuticals Ltd. Is dedicated to serve its valued customers with products of excellent quality through continuous improvement in technology, process and human resources complying with the guidelines of Current Good Manufacturing Practice (cGMP) and the requirements of ISO-9001:2000 Quality Management System (QMS) Navana Pharmaceuticals Ltd. is awared with WHO Standard cGMP & ISO-9001:2000 Certification in 2001.
N A V A N A Pharmaceuticals Ltd. is a Business Unit of Islam Group, which is one of the largest groups of Industries in Bangladesh having diversifying activities like Real estate, Construction, Information Technology, Banking, Fertilizer, Medical College& Hospital, Pharmaceuticals, Nursing Institutes, Agro & Poultry products and some other Business lines.
Navana’s mission is to build strengths carefully in important areas that offer the resources for tomorrow’s business opportunities.
to build customer’s trust as “Quality Company” both in products and services
to ensure health and sustainable growth of the company
to maintain the quality in all areas of operations by continuous development of Human Resource
Navana’s vision is to play the leading role in the country’s health sector by providing safe and effective medicine of high quality which will bring benefit to patients through improved longevity and quality of life. The pharmaceutical business is a composite of a variety professional background, including Pharmacist, Chemist, Biochemist, Engineer, Marketing Professional, Accountant & others. The founder chairman made certain commitments of principle at the onset to guide the company as it pursued is goals.
Act always with honesty, ethical and moral standards.
Adhere to standards of integrity in business and in products that benefit patients and inspire trust in Navana’s good name.
Embrace hands-on work ethic and a commitment to Navana’s success.
Exercise community stewardship by pursuing growth to provide more jobs for more families.
Share the blessings of success by giving first to the community and then to the world Leading Edge
Navana has gained a leading edge in many important therapeutic groups including Antibiotics, Antiulcer ants, Anitimigraines, Antivertigoes, Vitamins / Minerals, Opioid antagonist / Drug addiction treatment drugs. Navana Pharmaceuticals Ltd. Is dedicated to serve its valued customers with products of excellent quality through continuous improvement in technology, process and human resources complying with the guidelines of Current Good Manufacturing Practice (cGMP) and the requirements of ISO-9001:2000 Quality Management System (QMS) Navana Pharmaceuticals Ltd. is awared with WHO Standard cGMP & ISO-9001:2000 Certification in 2001.
Pharmaceuticals-Razu
DELTA Pharmaceutical Limited
Delta Pharmaceutical Limited has been propelling steadily towards its goal (Better Care... Better Cure...) since its launch on November 21, 2004 .We are strongly represented in the market by a growing line of products, some of which we were the first to introduce in this country. Its manufacturing plant is located in Kishoreganj with state-of-the-art technology and proven quality control & quality assurance. In manufacturing our products we procure high quality raw materials from reputed sources. Its management personnel are experienced and skilled professionals with distinguished career records. Their clear vision of the Company's target and their dynamic leadership are shaping Delta Pharmaceutical into a company capable of coping with any and all future challenges. The pharmaceutical arena can be seen as one of the most vital area affecting the health of a nation and thus the strength in this sector can define a country's growth and can affect it both adversely and favorably. Through quality, diligence and transparency Delta Pharmaceutical Limited is dedicated to providing the best in pharmaceutical care. Its aim to keep our customers satisfied and look to grow and in future seek to become a name of global reckoning. Our vision is to reach a level of excellence in pharmaceuticals through a sustained effort to quality assurance and to achieve a global standard through the indoctrination of a culture of excellence. Our mission is to benefit people and improve their quality of life through our quality products. As a generic company, our growth is closely knitted to the satisfaction of our customers. We would like to ensure customer satisfaction through providing quality medicine at affordable cost, launching new molecules & expediting export to all possible avenues. We are committed to achieving our goal through skilled, creative, and motivated employees. We are devoted to ensure quality in all our endeavors and to maintain the highest ethical standards in our business practices.
Delta Pharmaceutical Limited has been propelling steadily towards its goal (Better Care... Better Cure...) since its launch on November 21, 2004 .We are strongly represented in the market by a growing line of products, some of which we were the first to introduce in this country. Its manufacturing plant is located in Kishoreganj with state-of-the-art technology and proven quality control & quality assurance. In manufacturing our products we procure high quality raw materials from reputed sources. Its management personnel are experienced and skilled professionals with distinguished career records. Their clear vision of the Company's target and their dynamic leadership are shaping Delta Pharmaceutical into a company capable of coping with any and all future challenges. The pharmaceutical arena can be seen as one of the most vital area affecting the health of a nation and thus the strength in this sector can define a country's growth and can affect it both adversely and favorably. Through quality, diligence and transparency Delta Pharmaceutical Limited is dedicated to providing the best in pharmaceutical care. Its aim to keep our customers satisfied and look to grow and in future seek to become a name of global reckoning. Our vision is to reach a level of excellence in pharmaceuticals through a sustained effort to quality assurance and to achieve a global standard through the indoctrination of a culture of excellence. Our mission is to benefit people and improve their quality of life through our quality products. As a generic company, our growth is closely knitted to the satisfaction of our customers. We would like to ensure customer satisfaction through providing quality medicine at affordable cost, launching new molecules & expediting export to all possible avenues. We are committed to achieving our goal through skilled, creative, and motivated employees. We are devoted to ensure quality in all our endeavors and to maintain the highest ethical standards in our business practices.
Sunday, April 25, 2010
Pharmaceuticals- Razu
ESKAYEF Pharmaceuticals Limited
Eskayef Bangladesh Limited, the world-class healthcare solution provider, is one of the leading and fastest growing pharmaceutical company of Bangladesh, which is engaged in the manufacture and marketing of a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products with annual sales surpassing 60 million US dollars
With qualified, trained and skilled professionals on its staff and its unswerving standards of quality control, the company has distinguished itself as one of the most respected names in the pharmaceutical industry. Eskayef’s manufacturing facility has transcended the frontiers after the accreditation of UK MHRA (United Kingdom Medicines and Healthcare products Regulatory Agency). The dedicated cephalosporin plant of Eskayef Bangladesh Limited is the top class state-of-the-art manufacturing facility in Bangladesh pharmaceutical industry Eskayef is growing more global since 2005 and exporting bulk pellets and finished products in Asia, Africa, and Central America and also in the process of exporting in the European countries. The company is also tied up with the world leader in eye care solution Allergens Inc. Ireland. It is a quality driven company committed to our people and environment to provide world class healthcare solutions
Eskayef Bangladesh Limited, the world-class healthcare solution provider, is one of the leading and fastest growing pharmaceutical company of Bangladesh, which is engaged in the manufacture and marketing of a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products with annual sales surpassing 60 million US dollars
With qualified, trained and skilled professionals on its staff and its unswerving standards of quality control, the company has distinguished itself as one of the most respected names in the pharmaceutical industry. Eskayef’s manufacturing facility has transcended the frontiers after the accreditation of UK MHRA (United Kingdom Medicines and Healthcare products Regulatory Agency). The dedicated cephalosporin plant of Eskayef Bangladesh Limited is the top class state-of-the-art manufacturing facility in Bangladesh pharmaceutical industry Eskayef is growing more global since 2005 and exporting bulk pellets and finished products in Asia, Africa, and Central America and also in the process of exporting in the European countries. The company is also tied up with the world leader in eye care solution Allergens Inc. Ireland. It is a quality driven company committed to our people and environment to provide world class healthcare solutions
pharmaceuticals-Razu
BEXIMCO Pharmaceuticals Limited
Beximco Pharmaceuticals Ltd. ("BPL" or the "Company"), the leading edge pharmaceutical manufacturer and the largest pharmaceutical exporter of Bangladesh has commenced exports to Chile, after receiving marketing authorization for a number of products from "Instituto de Salud Publica de Chile" (Drug Regulatory authority in Chile). With this, BPL has become the first Bangladeshi pharmaceutical company to obtain product registration in any Latin American country, a company statement said today.Chile is one of the Latin America's better economic performers and is the sixth largest pharmaceutical market in the region. In 2007 Chilean pharmaceutical market was valued at US 1.5 billion dollar. The market is presently dominated by global brands of reputed MNCs as well as strong generics from domestic pharmaceutical companies. Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including Singapore and Hong Kong.Beximco Pharmaceuticals Limited.
Beximco Pharmaceuticals Ltd. ("BPL" or the "Company"), the leading edge pharmaceutical manufacturer and the largest pharmaceutical exporter of Bangladesh has commenced exports to Chile, after receiving marketing authorization for a number of products from "Instituto de Salud Publica de Chile" (Drug Regulatory authority in Chile). With this, BPL has become the first Bangladeshi pharmaceutical company to obtain product registration in any Latin American country, a company statement said today.Chile is one of the Latin America's better economic performers and is the sixth largest pharmaceutical market in the region. In 2007 Chilean pharmaceutical market was valued at US 1.5 billion dollar. The market is presently dominated by global brands of reputed MNCs as well as strong generics from domestic pharmaceutical companies. Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including Singapore and Hong Kong.Beximco Pharmaceuticals Limited.
pharmaceuticals-razu
INCEPTA pharmaceutical limited
INCEPTA pharmaceutical limited is a leading company in Bangladesh established in the year in 1999. The company has a very big manufacturing facilities located at shaver, 35 kilometer away from the center of the capital city Dhaka. The company produces various types of dosage from which include Tablates, capsules, oral liquids, dry powder vials, powder for suspensions, nasal sprays etc. Since its inception INCEPTA has been launching new and innovative products in order to fulfillment demand of the medical community. The focus was to bring more technologically advanced molecules to this county. It has established a modern research and development laboratory for the development of new advance dosage forms for various drugs and devices poorly soluble drugs. The company virtually covers every single corner of the rural as well as urban area of Bangladesh. It has its own large distribution network having 13 depots all over the country. The company has a clear vision to be a leading research base dosage form manufacturing company with global presence within short period of time. The company is now expanding its activities beyond the geographical boundary of Bangladesh. The products are of high standard and there fore these will be exported to both developed and developing countries.INCEPTA will continue to strive to provide high quality medicine at affordable prices to the people here in Bangladesh and other parts of the globe.
INCEPTA pharmaceutical limited is a leading company in Bangladesh established in the year in 1999. The company has a very big manufacturing facilities located at shaver, 35 kilometer away from the center of the capital city Dhaka. The company produces various types of dosage from which include Tablates, capsules, oral liquids, dry powder vials, powder for suspensions, nasal sprays etc. Since its inception INCEPTA has been launching new and innovative products in order to fulfillment demand of the medical community. The focus was to bring more technologically advanced molecules to this county. It has established a modern research and development laboratory for the development of new advance dosage forms for various drugs and devices poorly soluble drugs. The company virtually covers every single corner of the rural as well as urban area of Bangladesh. It has its own large distribution network having 13 depots all over the country. The company has a clear vision to be a leading research base dosage form manufacturing company with global presence within short period of time. The company is now expanding its activities beyond the geographical boundary of Bangladesh. The products are of high standard and there fore these will be exported to both developed and developing countries.INCEPTA will continue to strive to provide high quality medicine at affordable prices to the people here in Bangladesh and other parts of the globe.
Wednesday, April 21, 2010
Square pharmaceuticals limited Bangladesh
· The Leader of Bangladesh Pharma Market Since 1985
· SQUARE today symbolizes a name - a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global play
·
·
· The company was founded in 1958 by Samson H. Chowdhury along with three of his friends as a private firm. It went public in 1991 and is currently listed on the Dhaka stock exchange Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and it has been continuously in the 1st position among all national and multinational companies since 1985. Square Pharmaceuticals Ltd. is now on its way to becoming a high performance global player
· The Leader of Bangladesh Pharma Market Since 1985
· SQUARE today symbolizes a name - a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global play
·
·
· The company was founded in 1958 by Samson H. Chowdhury along with three of his friends as a private firm. It went public in 1991 and is currently listed on the Dhaka stock exchange Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and it has been continuously in the 1st position among all national and multinational companies since 1985. Square Pharmaceuticals Ltd. is now on its way to becoming a high performance global player
Subscribe to:
Posts (Atom)